These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The metabolic pathology of dopa-responsive dystonia. Asanuma K; Ma Y; Huang C; Carbon-Correll M; Edwards C; Raymond D; Bressman SB; Moeller JR; Eidelberg D Ann Neurol; 2005 Apr; 57(4):596-600. PubMed ID: 15786454 [TBL] [Abstract][Full Text] [Related]
43. Dopa-responsive dystonia: pathological and biochemical observations in a case. Rajput AH; Gibb WR; Zhong XH; Shannak KS; Kish S; Chang LG; Hornykiewicz O Ann Neurol; 1994 Apr; 35(4):396-402. PubMed ID: 7908789 [TBL] [Abstract][Full Text] [Related]
44. A novel mutation of the GTP-cyclohydrolase I gene in a patient with hereditary progressive dystonia/dopa-responsive dystonia. Imaiso Y; Taniwaki T; Yamada T; Yoshimura T; Hirano M; Ueno S; Kaneda N; Kira J Neurology; 1998 Feb; 50(2):517-9. PubMed ID: 9484387 [TBL] [Abstract][Full Text] [Related]
45. A novel de novo point mutation in the GTP cyclohydrolase I gene in a Japanese patient with hereditary progressive and dopa responsive dystonia. Sasaki R; Naito Y; Kuzuhara S J Neurol Neurosurg Psychiatry; 1998 Dec; 65(6):947. PubMed ID: 9854983 [No Abstract] [Full Text] [Related]
46. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849 [TBL] [Abstract][Full Text] [Related]
52. Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy. Perry D; Birthi P; Salles S; McDowell S PM R; 2012 May; 4(5):383-4. PubMed ID: 22613365 [No Abstract] [Full Text] [Related]
53. Dopa responsive dystonia and the Indian literature. Nair KR J Assoc Physicians India; 1995 Mar; 43(3):233-4. PubMed ID: 11256929 [No Abstract] [Full Text] [Related]
54. Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene. Furukawa Y; Kish SJ; Lang AE Neurology; 2000 Jun; 54(11):2187. PubMed ID: 10851395 [No Abstract] [Full Text] [Related]
55. Dopa-responsive dystonia (Segawa syndrome). Kamal N; Bhat DP; Carrick E Indian Pediatr; 2006 Jul; 43(7):635-8. PubMed ID: 16891685 [TBL] [Abstract][Full Text] [Related]
56. Dopa-responsive dystonia -- the story so far. Bandmann O; Wood NW Neuropediatrics; 2002 Feb; 33(1):1-5. PubMed ID: 11930268 [TBL] [Abstract][Full Text] [Related]
57. Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopamine deficiency. Jeon BS; Jeong JM; Park SS; Lee MC Adv Neurol; 1998; 78():309-17. PubMed ID: 9750927 [No Abstract] [Full Text] [Related]
58. Delayed Diagnosis of Dopa responsive Dystonia in Two Siblings. Jain R; Shukla B; Mittal M Indian Pediatr; 2016 May; 53(5):427-8. PubMed ID: 27254057 [TBL] [Abstract][Full Text] [Related]
59. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Nygaard TG Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194 [No Abstract] [Full Text] [Related]
60. Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. Hirano M; Imaiso Y; Ueno S Biochem Biophys Res Commun; 1997 May; 234(2):316-9. PubMed ID: 9177267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]